Tenet Healthcare (NYSE:THC) updated its FY 2018 earnings guidance on Monday. The company provided earnings per share guidance of $1.44-1.83 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.74. The company issued revenue guidance of $18.1-18.3 billion, compared to the consensus revenue estimate of $18.13 billion.Tenet Healthcare also updated its Q4 guidance to $0.10-0.48 EPS.
THC has been the subject of a number of research reports. ValuEngine upgraded Tenet Healthcare from a sell rating to a hold rating in a report on Thursday, November 1st. Piper Jaffray Companies restated a hold rating and issued a $34.00 price target on shares of Tenet Healthcare in a research note on Wednesday, August 8th. Barclays began coverage on Tenet Healthcare in a research report on Tuesday, August 14th. They issued an equal weight rating and a $35.00 price objective for the company. Zacks Investment Research raised Tenet Healthcare from a hold rating to a buy rating and set a $36.00 price objective for the company in a research report on Wednesday, August 8th. Finally, Mizuho set a $36.00 price objective on Tenet Healthcare and gave the company a buy rating in a research report on Tuesday, August 7th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of Hold and an average price target of $30.80.
NYSE:THC traded down $3.42 during mid-day trading on Tuesday, hitting $23.78. 91,670 shares of the stock were exchanged, compared to its average volume of 1,260,530. The stock has a market cap of $2.78 billion, a P/E ratio of 29.44, a PEG ratio of 1.22 and a beta of 0.87. The company has a current ratio of 1.08, a quick ratio of 1.01 and a debt-to-equity ratio of 24.66. Tenet Healthcare has a fifty-two week low of $12.45 and a fifty-two week high of $39.74.
Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Monday, November 5th. The company reported $0.29 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.11 by $0.18. Tenet Healthcare had a positive return on equity of 38.91% and a negative net margin of 2.51%. The firm had revenue of $4.49 billion during the quarter, compared to analysts’ expectations of $4.37 billion. During the same period in the previous year, the firm earned ($0.17) EPS. The company’s quarterly revenue was down 2.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Tenet Healthcare will post 1.72 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Tenet Healthcare (THC) Updates FY 2018 Earnings Guidance” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/11/06/tenet-healthcare-thc-updates-fy-2018-earnings-guidance.html.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Recommended Story: What are the reasons investors use put options?
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.